Literature DB >> 18414509

The polymorphisms of protein-tyrosine phosphatase receptor-type delta gene and its association with pediatric asthma in the Taiwanese population.

Shyh-Dar Shyur1, Jiu-Yao Wang, Cherry Guan-Ju Lin, Ya-Hsin Hsiao, Ya-Huei Liou, Ying-Jye Wu, Lawrence Shih-Hsin Wu.   

Abstract

We previously reported an association between genetic differences of pediatric asthma subtypes and a short tandem repeat (STR) marker, D9S286. It has been known that the protein-tyrosine phosphatase receptor-type delta (PTPRD) gene is located downstream of D9S286 and that the physical distance between them is about 0.25 Mb. We selected and conducted genotyping on 76 single-nucleotide polymorphisms (SNPs) that encircle the genomic region of PTPRD in Taiwanese children with or without asthma. A total of 996 subjects were divided into testing group (674 subjects) and validation group (322 subjects). The results were further validated with the third subject group (611 subjects) recruited from different geographical regions. After Bonferroni correction, 3 out of 80 SNPs were found to be strongly significant (P < 0.05/76 = 0.000658) in the allele frequency test. This association was confirmed by validation groups. The results indicate that polymorphisms of PTPRD are strongly associated with pediatric bronchial asthma in the Taiwanese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18414509     DOI: 10.1038/ejhg.2008.79

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

1.  Genome-wide association study of severity in multiple sclerosis.

Authors: 
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

2.  Analyses of shared genetic factors between asthma and obesity in children.

Authors:  Erik Melén; Blanca E Himes; John M Brehm; Nadia Boutaoui; Barbara J Klanderman; Jody S Sylvia; Jessica Lasky-Su
Journal:  J Allergy Clin Immunol       Date:  2010-09       Impact factor: 10.793

3.  Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5).

Authors:  Dianne M Walters; Kevin M White; Ushma Patel; Martin J Davis; Roberta M Veluci-Marlow; Solomon Raju Bhupanapadu Sunkesula; James C Bonner; Jessica R Martin; Wes Gladwell; Steven R Kleeberger
Journal:  FASEB J       Date:  2013-11-27       Impact factor: 5.191

Review 4.  An understanding of the genetic basis of asthma.

Authors:  Mahdi Bijanzadeh; Padukudru A Mahesh; Nallur B Ramachandra
Journal:  Indian J Med Res       Date:  2011-08       Impact factor: 2.375

5.  Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study.

Authors:  Noffisat O Oki; Alison A Motsinger-Reif; Paulo Rz Antas; Shawn Levy; Steven M Holland; Timothy R Sterling
Journal:  BMC Res Notes       Date:  2011-01-31

6.  Rank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populations.

Authors:  Lili Ding; Tilahun Abebe; Joseph Beyene; Russell A Wilke; Arnon Goldberg; Jessica G Woo; Lisa J Martin; Marc E Rothenberg; Marepalli Rao; Gurjit K Khurana Hershey; Ranajit Chakraborty; Tesfaye B Mersha
Journal:  Hum Genomics       Date:  2013-07-05       Impact factor: 4.639

7.  Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle.

Authors:  Philip J Austin; Eleni Tsitsiou; Charlotte Boardman; Simon W Jones; Mark A Lindsay; Ian M Adcock; Kian Fan Chung; Mark M Perry
Journal:  J Allergy Clin Immunol       Date:  2016-07-02       Impact factor: 10.793

8.  Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes.

Authors:  J Elia; X Gai; H M Xie; J C Perin; E Geiger; J T Glessner; M D'arcy; R deBerardinis; E Frackelton; C Kim; F Lantieri; B M Muganga; L Wang; T Takeda; E F Rappaport; S F A Grant; W Berrettini; M Devoto; T H Shaikh; H Hakonarson; P S White
Journal:  Mol Psychiatry       Date:  2009-06-23       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.